Metropolitan Life Insurance Company (MetLife)’s Pure Cycle PCYO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,071
Closed -$10.2K 1523
2024
Q1
$10.2K Hold
1,071
﹤0.01% 2127
2023
Q4
$11.2K Hold
1,071
﹤0.01% 2146
2023
Q3
$10.3K Hold
1,071
﹤0.01% 2191
2023
Q2
$11.8K Buy
1,071
+667
+165% +$6.62K ﹤0.01% 2219
2023
Q1
$3.82K Sell
404
-870
-68% -$8.02K ﹤0.01% 2284
2022
Q4
$13.4K Hold
1,274
﹤0.01% 2179
2022
Q3
$10.6K Hold
1,274
﹤0.01% 2278
2022
Q2
$13.4K Hold
1,274
﹤0.01% 2232
2022
Q1
$15.3K Sell
1,274
-841
-40% -$10.4K ﹤0.01% 2202
2021
Q4
$30.9K Sell
2,115
-3,052
-59% -$45.7K ﹤0.01% 2734
2021
Q3
$68.8K Buy
+5,167
New +$74.8K ﹤0.01% 2707
2020
Q2
Sell
-5,729
Closed -$63.9K 2581
2020
Q1
$63.9K Buy
+5,729
New +$69.5K ﹤0.01% 2295

Other funds holding PCYO

Metropolitan Life Insurance Company (MetLife)'s PCYO Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Pure Cycle (PCYO) in Q2 2024, closing a stake of 1,071 shares — an estimated $10.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PCYO in Q1 2020 and held it in 12 quarters. The position peaked at $68.8K in Q3 2021. 97 funds tracked by Wall St. Rank hold PCYO as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Pure Cycle position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,071 Pure Cycle shares in Q2 2024, an estimated $10.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Pure Cycle in Q1 2020 and held it in 12 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Pure Cycle position peaked at $68.8K in Q3 2021.
  • 97 funds tracked by Wall St. Rank held Pure Cycle as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.